Psilocybin therapy significantly decreased moderate to severe symptoms of depression in clinicians after frontline work ...

The Alzheimer's Association revised the diagnostic criteria for Alzheimer disease (AD) and ADRD for clinicians in primary and specialty care.

A digital-based therapy using a mobile application with recording and analytic functions can relieve symptoms of insomnia and depression among people age 15 to 25, according to a team of scientists ...

Seeking mental health help is a significant step, but that first intake session can often feel more like paperwork than ...

More than 280 million people live with depression, according to the World Health Organization. People experience the ...

Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Pain catastrophizing and anxiety in pediatric patients with chronic pain were associated with depressive symptoms, and both factors were significantly modified by ethnicity.

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...

In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.

CBT is the gold standard therapy for treating depression and anxiety, one or both of which will afflict around 20 percent of people during their lifetime. It may be the best remedy we have, a ...